EUVIMEDEUVIMED entdecken
Open Access

Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study

Debbie W Chen, Grant Carr, Francis P Worden, Christine M Veenstra, Megan R Haymart iD, Mousumi Banerjee

Thyroid® · 2024-07 · 34 (7) · 837-845

DOI: 10.1089/thy.2023.0709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 12.07.2024. Verfasst von Debbie W Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, SEER Program. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For patients with thyroid cancer, distant metastasis is a significant predictor of poor outcome. Since distant metastasis occurs in less than 10% of patients with differentiated thyroid cancer, correlates of survival in this vulnerable patient population remain understudied. This study aimed to identify prognostic groups among patients with differentiated thyroid cancer and distant metastases and to determine the role of, and interactions between, patient and tumor characteristics in determining survival.

Methods

We identified adult patients diagnosed with differentiated thyroid cancer with distant metastases from the U.S. SEER-17 cancer registry (2010–2019). Analyses were performed using Cox proportional hazards regression, survival trees, and random survival forest. Relative importance of patient and tumor factors important for disease-specific and overall survival was assessed based on the random survival forest analyses.

Results

Cohort consisted of 2411 patients with differentiated thyroid cancer with distant metastases followed for a median of 62 months. Most common histopathologic subtype (86.0%) was papillary thyroid cancer, and the most common sites of distant metastasis were the lungs (33.7%) and bone (18.9%). Cox proportional hazards model illustrated significant associations between survival and the following: patient age ( p < 0.001), tumor size ( p < 0.01), and site of distant metastasis ( p < 0.05). Survival tree analyses identified three distinct prognostic groups based on disease-specific survival (DSS) (5-year survival of the prognostic groups was 92%, 64%, and 41%; p < 0.001) and four distinct prognostic groups based on overall survival (OS) (5-year survival of the prognostic groups was 96%, 84%, 57%, and 31%; p < 0.001). The first split in the survival trees for DSS and OS was by age at diagnosis (≤57 years vs. ≥58 years) with subsequent splits based on presence/absence of lung metastases, tumor size (≤4 cm vs. >4 cm), and patient age. A total of 558 patients (23.1%) died from thyroid cancer, and 757 patients (31.4%) died from all causes during the study period.

Conclusions

This study identifies distinct prognostic groups for patients with differentiated thyroid cancer with distant metastases and highlights the importance of patient age, lung metastases, and tumor size for determining both disease-specific and overall survival. These findings inform risk stratification and treatment decision-making in this understudied patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsSEER ProgramHumansMaleFemaleMiddle AgedPrognosisAdultAgedUnited StatesLung NeoplasmsProportional Hazards ModelsNeoplasm MetastasisBone NeoplasmsThyroid Cancer, PapillaryAdenocarcinoma, Follicular

Stichwörter der Autor:innen

disease-specific survivallung metastasesoverall survivalthyroid cancer

Autor:innen und Institutionen

  • Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Megan R Haymart

Förderung

  • NCI NIH HHS

Zitieren

APA

Chen, D. W., Carr, G., Worden, F. P., Veenstra, C. M., Haymart, M. R., & Banerjee, M. (2024). Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study. Thyroid®, 34(7), 837-845. https://doi.org/10.1089/thy.2023.0709

Vancouver

Chen DW, Carr G, Worden FP, Veenstra CM, Haymart MR, Banerjee M. Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study. Thyroid®. 2024;34(7):837-845. doi:10.1089/thy.2023.0709

BibTeX
@article{Chen2024,
  author = {Chen, Debbie W and Carr, Grant and Worden, Francis P and Veenstra, Christine M and Haymart, Megan R and Banerjee, Mousumi},
  title = {Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study},
  journal = {Thyroid®},
  year = {2024},
  volume = {34},
  number = {7},
  pages = {837--845},
  doi = {10.1089/thy.2023.0709}
}
Kostenlos starten →